Health knowledge and news provided by doctors.

GammaPod: The Next Generation for Breast Cancer Treatment

Kathleen Blanchard's picture

Entrepreneur of the Year Cedric Yu, DSc has developed the GammaPod system that could be the next generation for early breast cancer treatment. The device could eliminate the need for breast cancer surgery and could mean only two or three treatments. Most breast cancer is diagnosed early, but frequently cells remain outside of the tumor.

The GammaPod, patented in 2006, and developed with the help of $3.5 million in Small Business Innovation Research grants from the National Institutes of Health (NIH) could be the next generation for early breast cancer treatment.

GammaPod Eradicates Breast Cancer without Pain and Scars

Yu explains, “We can deliver a high enough dose to [neutralize] the tumor. Only two or three radiation treatments will be needed. The traditional 3-month ordeal can be shortened to three treatments only. You don’t need surgery. You don’t need standard radiation. No needle, knife, pain, anesthesia, and no scar.”

Follow eMaxHealth on YouTube, Twitter and Facebook.
Please, click to subscribe to our Youtube Channel to be notified about upcoming health and food tips.

Changing the way breast cancer is treated poses challenges, but Yu hopes the device will be approved by the end of the year. He says, changing the way breast cancer is treated "will take money, time, support of the university, hard work, but we will do it right", noting that it won't be easy.

The GammaPod is a new product that won the title Entrepreneur of the Year for Yu who said “I was surprised and happy to be named Entrepreneur of the Year, not just for myself but happy that the University encourages entrepreneurship and recognizes the importance of theoretical research that converts into new knowledge and new products.”

The GammaPod could revolutionize the treatment of early breast cancer that can eliminate cancer cells left outside the tumor site that both surgery and multiple radiation treatments fail to reach at even the highest doses. William Regine, MD, chair of the School’s Department of Radiation Oncology says, “It’s a solution that could eventually lead to the use of SBRT [Stereotactic Body Radiation Therapy] alone, that is, no surgery, thus, leaving women with no need of a scar to remind them of their breast cancer."

University of Maryland

Copyright © November 14, 2010
Kathleen Blanchard RN

Updated 5/25/2015